novo nordisk semaglutide clinical trials

novo nordisk semaglutide clinical trials Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients Novo Nordisk Sinks on Disappointing

Name: novo nordisk semaglutide clinical trials Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients Novo Nordisk Sinks on Disappointing
Brand: www.rasophiles.fr
SKU: 52975991310
Price: 28.47 USD
Availability: InStock
Rating: 4.5616 (11 reviews)

SKU: 52975991310

4.6

EUR28.47 EUR52.47

Pay in 4 interest-free payments of $7.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

BMJ Med 1(1):e000308 Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX et al (2015) Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)

The results were heterogeneous: some trials, such as AMPLITUDE-O and SELECT, demonstrated significant reductions in HF-related endpoints, whereas others, like LEADER, showed only non-significant favourable trends